About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Meet the Cure Team Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Konstantinos Aprilakis, M.D.

Konstantinos Aprilakis, M.D., is a Partner on the Therapeutics team and joined the Firm in 2021. He provides extensive research and analysis on individual companies operating in the healthcare industry. Prior to Deerfield, Dr. Aprilakis spent five years as a research analyst covering the Biotechnology sector, most recently as a Managing Director at Stifel Financial Corp. Before Stifel, Dr. Aprilakis was a Director for Deutsche Bank and a Vice President for JMP Securities. Prior to entering the finance industry, Dr. Aprilakis conducted biomedical research as a Howard Hughes Medical Institute research scholar at Stony Brook University and Weill Cornell Medical College. Dr. Aprilakis received his B.A. in Philosophy from Stony Brook University and his M.D. from Weill Cornell Medical College.